Search results
Results from the WOW.Com Content Network
Exocrine pancreatic insufficiency (EPI) is the inability to properly digest food due to a lack or reduction of digestive enzymes made by the pancreas.EPI can occur in humans and is prevalent in many conditions [1] such as cystic fibrosis, [2] Shwachman–Diamond syndrome, [3] different types of pancreatitis, [4] multiple types of diabetes mellitus (Type 1 and Type 2 diabetes), [5] advanced ...
Peas also contain nearly 7% of your daily amount of iron, Derocha adds, which is a good reminder "because often people think (iron has to come from) liver, organ meats or a steak, but it doesn't ...
Differential diagnosis: Gastroesophageal reflux disease, gastroparesis, and irritable bowel syndrome. [1] Treatment: Symptom control. [2] Medication: Proton pump inhibitors, H2 receptor antagonists, antidepressants, and prokinetic agents. [2] Prognosis: 15% to 20% of patients have persistent symptoms during extended follow-up. [2] Frequency: 5 ...
Indigestion is a diagnosis related to a combination of symptoms that can be attributed to "organic" or "functional" causes. [13] Organic dyspepsia should have pathological findings upon endoscopy, like an ulcer in the stomach lining in peptic ulcer disease . [ 13 ]
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) recommends testing for diabetes in people: Who have overweight or obesity and one or more other risk factors for diabetes
A low-FODMAP diet is a person's global restriction of consumption of all fermentable carbohydrates (), [1] recommended only for a short time. A low-FODMAP diet is recommended for managing patients with irritable bowel syndrome (IBS) and can reduce digestive symptoms of IBS including bloating and flatulence.
A low-FODMAP diet might help to improve short-term digestive symptoms in adults with irritable bowel syndrome, [120] [114] [121] [20] but its long-term follow-up can have negative effects because it causes a detrimental impact on the gut microbiota and metabolome.
Fructose malabsorption, formerly named dietary fructose intolerance (DFI), is a digestive disorder [1] in which absorption of fructose is impaired by deficient fructose carriers in the small intestine's enterocytes. This results in an increased concentration of fructose. Intolerance to fructose was first identified and reported in 1956. [2]